Clinical Trial Update: Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating probiotics to prevent preterm birth and related neonatal morbidity was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis
• Bronchopulmonary Dysplasia
• Periventricular Leukomalacia
• Preterm Birth
• Sepsis

Drugs mentioned

• Probiotic therapy (unspecified formulation) (Probiotic)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: Bacterial Vaginosis, Premature Birth | Phase 3 | Status: TERMINATED